The epidemiology of Parkinson's disease.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Baillière's Clinical Neurology

• Publication date

  1997-04-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  PMID 9426868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How far are we in understanding the cause of Parkinson's disease?

  1996cited by this paper
• Prevalence of parkinsonian signs and associated mortality in a community population of older people.

  1996cited by this paper
• Whooping Cough and Parkinson's Disease

  1996cited by this paper
• Possible environmental, occupational, and other etiologic factors for Parkinson's disease

  1996cited by this paper
• Case‐control study of idiopathic Parkinson's disease and dietary vitamin E intake

  1996cited by this paper
• Does levodopa therapy delay death in Parkinson's disease? A review of the evidence

  1995cited by this paper
• Rising mortality from Parkinson's disease in Japan, 1950–1992

  1995cited by this paper
• The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993.

  1995cited by this paper
• High levodopa use in periodically time‐clustered, Icelandic birth cohorts. A vestige of parkinsonism etiology?

  1995cited by this paper
• Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?

  1995cited by this paper
• Parkinson's disease in Kin-Hu, Kinmen: a community survey by neurologists.

  1994cited by this paper
• Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France

  1994cited by this paper
• Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

  1994cited by this paper
• Oxidative damage in neurodegenerative disease.

  1994cited by this paper
• Mortality in relation to smoking: 40 years' observations on male British doctors

  1994cited by this paper
• Environmental antecedents of young‐onset Parkinson's disease

  1993cited by this paper
• Mortality from Parkinson's disease in England and Wales 1921-89.

  1993cited by this paper
• A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China.

  1993cited by this paper
• Worldwide occurrence of Parkinson's disease: an updated review.

  1993cited by this paper
• Induction of cytochrome P-450 enzymes via tobacco smoke: a potential mechanism for developing resistance to environmental toxins as related to parkinsonism and other neurologic diseases.

  1993cited by this paper
• Personality and cigarette smoking in Italy, Poland, and the United States.

  1993cited by this paper
• Smoking and neurogenerative diseases.

  1993cited by this paper
• Smoking and mitochondrial function: a model for environmental toxins.

  1993cited by this paper
• Risk factors for Parkinson's disease

  1993cited by this paper
• The epidemiology of Parkinson's disease in the Republic of Ireland: observations from routine data sources.

  1993cited by this paper
• Prognostic significance of the onset mode in parkinsonism

  1993cited by this paper
• Parkinson's disease

  1993cited by this paper
• When does Parkinson's disease begin?

  1992cited by this paper
• Exposure to well water and pesticides in Parkinson's disease: A case‐control study in the madrid area

  1992cited by this paper
• Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: A case‐control study

  1992cited by this paper
• Mortality rates for Parkinson's disease and parkinsonism in Italy (1969-1987).

  1992cited by this paper
• Prevalence of Parkinson's disease and other types of parkinsonism

  1992cited by this paper
• Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.

  1992cited by this paper
• Parkinson's disease and exposure to agricultural work and pesticide chemicals

  1992cited by this paper
• Cigarette smoking and Parkinson disease: the illusion of a neuroprotective effect.

  1992cited by this paper
• Rising mortality due to Parkinson's disease and amyotrophic lateral sclerosis: a manifestation of the competitive nature of human mortality.

  1992cited by this paper
• Parkinson's disease incidence: magnitude, comparability, time trends

  1991cited by this paper
• Environmental risk factors in siblings with Parkinson's disease.

  1991cited by this paper
• Parkinson's Disease and Exposure to Rural Environmental Factors: A Population Based Case-Control Study

  1991cited by this paper
• Brain injury and neurologic sequelae

  1991cited by this paper
• The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients.

  1991cited by this paper
• The changing patterns of death rates in parkinsonism

  1990cited by this paper
• Parkinson's disease in Aberdeen: survival after 3.5 years

  1990cited by this paper
• Premorbid personality and idiopathic Parkinson's disease.

  1990cited by this paper
• Two decades of increasing mortality from Parkinson's disease among the US elderly.

  1990cited by this paper
• Follow‐up study of early‐life protective and risk factors in Parkinson's disease

  1990cited by this paper
• Environmental risk factors in Parkinson's disease

  1990cited by this paper
• An examination of male‐female differences in progression and mortality of Parkinson's disease

  1990cited by this paper
• Epidemiologic study of Parkinson's disease in Hong Kong

  1989cited by this paper
• S-methylation in motorneuron disease and Parkinson's disease.

  1989cited by this paper
• Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease.

  1989cited by this paper
• Effect of age at onset on progression and mortality in Parkinson's disease

  1989cited by this paper
• Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis.

  1988cited by this paper
• A case‐control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease

  1987cited by this paper
• Geography, Drinking Water Chemistry, Pesticides and Herbicides and the Etiology of Parkinson's Disease

  1987cited by this paper
• Early Onset Parkinson's Disease in Saskatchewan - Environmental Considerations for Etiology

  1986cited by this paper
• Monoamine oxidase B, smoking, and Parkinson's disease.

  1986cited by this paper
• Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi

  1985cited by this paper
• Morbidity and mortality in motor neuron disease: comparison with multiple sclerosis and Parkinson's disease: age and sex specific rates and cohort analyses.

  1985cited by this paper
• Measles infection and Parkinson's disease.

  1985cited by this paper
• Epidemiology of parkinsonism: Incidence, classification, and mortality

  1984cited by this paper
• Effect of L-dopa on course of Parkinson's disease.

  1984cited by this paper
• Parkinson's disease in 65 pairs of twins and in a set of quadruplets

  1983cited by this paper
• 1918 influenza, encephalitis lethargica, parkinsonism.

  1982cited by this paper
• Nicotine exposure and Parkinson disease.

  1981cited by this paper
• Search for viral particles and virus‐specific products in idiopathic Parkinson disease brain material

  1979cited by this paper
• Viral antibodies in serum and CSF of Parkinsonian patients and controls.

  1979cited by this paper
• Viral antibodies in the sera from patients with Parkinson disease.

  1977cited by this paper
• Occurrence of Parkinson's disease in black patients at Charity Hospital in New Orleans

  1974cited by this paper
• Epidemiologic studies of Parkinson's disease. 3. A community-based survey.

  1972cited by this paper
• Parkinsonism

  1967cited by this paper
• COHORT ANALYSIS OF PARKINSON'S SYNDROME: EVIDENCE FOR A SINGLE ETIOLOGY RELATED TO SUBCLINICAL INFECTION ABOUT 1920.

  1963cited by this paper

• Movement Disorders.

  2022cites this paper
• Concussion susceptibility is mediated by spreading depolarization-induced neurovascular dysfunction

  2021cites this paper
• A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy

  2020cites this paper
• Investigating early functional alteration in a human iPSC-based model of Parkinson’s Disease

  2019cites this paper
• Fréquence et profil clinique de la maladie de Parkinson et des autres syndromes Parkinsoniens vus au service de neurologie de l'hôpital Befelatanana Antananarivo

  2019cites this paper
• Risk Assessment Forum

  2018cites this paper
• Caspase-1 causes truncation and aggregation of the Parkinson’s disease-associated protein α-synuclein

  2016cites this paper
• Parkinsonism and Related Disorders

  2016cites this paper
• A Plant-Food Diet in the Risk and Management of Parkinson’s Disease

  2015cites this paper
• Experiences of apathy in people with Parkinson’s disease: a qualitative exploration

  2015cites this paper
• A FRAMEWORK FOR CHARACTERIZING REGIONAL ALTERATIONS IN DOPAMINE NEUROTRANSMISSION IN THE CONTEXT OF DRUGS AND DISEASE USING FAST-SCAN CYCLIC VOLTAMMETRY

  2015cites this paper
• Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology

  2014cites this paper
• Psychiatric diseases predated the occurrence of Parkinson disease: a retrospective cohort study.

  2014cites this paper
• Psychosis In Parkinson’s Disease Patients

  2013cites this paper
• Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression.

  2013cites this paper
• Acute complications of movement disorders surgery: Effects of age and comorbidities

  2013cites this paper
• Functional neurosurgery in Parkinson's disease: a long journey from destruction over modulation towards restoration.

  2013cites this paper
• Prevention of Parkinson’s disease: preparing for the future

  2013cites this paper
• Management of upper extremity dysfunction in people with Parkinson disease and Huntington disease: facilitating outcomes across the disease lifespan.

  2013cites this paper
• The Role of Dopamine Replacement on the Behavioural Phenotype of Parkinson’s Disease

  2013cites this paper
• Costs of Illness in a Russian Cohort of Patients with Parkinson’s Disease

  2012cites this paper
• Factors related to functional independence in females with Parkinson's disease: a systematic review.

  2011cites this paper
• Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review.

  2011cites this paper
• Epidemiology and etiology of Parkinson’s disease: a review of the evidence

  2011cites this paper
• The prevalence of Parkinson's disease in a rural area of North-East England.

  2010cites this paper
• Mild traumatic brain injury: a risk factor for neurodegeneration

  2010cites this paper
• Healthy brain aging: effect of head injury, alcohol and environmental toxins.

  2010cites this paper
• Multi-parametric system for the continuous assessment and monitoring of motor status in Parkinson's disease: An entropy-based gait comparison

  2009cites this paper
• Brain Insulin-Like Growth Factor and Neurotrophin Resistance in Parkinson's Disease and Dementia with Lewy Bodies: Potential Role of Manganese Neurotoxicity

  2009cites this paper
• Diagnosis and management of Parkinson's disease: what the NICE guidelines say, and why

  2008cites this paper
• Prevalence of movement disorders in an elderly nursing home population.

  2008cites this paper
• Pesticide exposure and risk of Parkinson's disease: A family-based case-control study

  2008cites this paper
• Meeting Report: Consensus Statement—Parkinson’s Disease and the Environment: Collaborative on Health and the Environment and Parkinson’s Action Network (CHE PAN) Conference 26–28 June 2007

  2008cites this paper
• Helicobacter Hypothesis for Idiopathic Parkinsonism: Before and Beyond

  2008cites this paper
• The prevalence of Parkinson's disease among

  2008cites this paper
• ENVIRONMENTAL PERSPECTIVES ENVIRONMENTAL PERSPECTIVES

  2008cites this paper
• Sequential and concerted gene expression changes in a chronic in vitro model of parkinsonism.

  2008cites this paper
• Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans.

  2007cites this paper
• An Investigation of the Cognitive and Psychiatric Profile for People with Parkinson's Disease Without Dementia.

  2007cites this paper
• Literature-Related Discovery (LRD)

  2007cites this paper
• Parkinson's disease.

  2007cites this paper
• Infectious basis to the pathogenesis of Parkinson's disease.

  2007cites this paper
• Protein accumulation in traumatic brain injury

  2007cites this paper
• Idiopathic parkinsons disease: epidemiology, diagnosis and management

  2006cites this paper
• Aus dem Zentrum für Neurologie der Universität Tübingen Abteilung Neurologie mit Schwerpunkt Neurodegenerative Erkrankungen

  2006cites this paper
• The Prevalence of Parkinson’s Disease in an Area of North Tyneside in the North-East of England

  2006cites this paper
• Gene–environment interactions in sporadic Parkinson's disease

  2006cites this paper
• Early Environmental Origins of Neurodegenerative Disease in Later Life

  2005cites this paper
• Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort.

  2005cites this paper
• An overview of parkinsonian syndromes: data from the literature and from an Italian data-base.

  2004cites this paper
• Cortical and Subcortical Dynamics of Aging with HIV Infection

  2004cites this paper
• Treatment Benefit and Daily Drug Costs Associated with Treating Parkinson’s Disease in a Parkinson’s Disease Clinic

  2004cites this paper
• Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.

  2003cites this paper
• Parkinson's Disease: Genetic Epidemiology and Overview

  2003cites this paper
• Does this patient have Parkinson disease?

  2003cites this paper
• Manganese ethylene‐bis‐dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction

  2003cites this paper
• Morbus Parkinson und Diabetes mellitus

  2002cites this paper
• The Curious Negative (Protective?) Associations between Parkinson’s Disease and Certain Behavioral Risk Factors

  2002cites this paper
• Environmental factors in Parkinson's disease.

  2002cites this paper
• Older Swedish women's experiences of living with symptoms related to Parkinson's disease.

  2002cites this paper
• Proportionate mortality of crop and livestock farmers in the United States, 1984-1993.

  2002cites this paper
• Case–control study of environmental risk factors for Parkinson's disease in Belgium

  2002cites this paper
• Mice with Very Low Expression of the Vesicular Monoamine Transporter 2 Gene Survive into Adulthood: Potential Mouse Model for Parkinsonism

  2001cites this paper
• The epidemiology of Parkinson's disease. Current issues.

  2001cites this paper
• Parkinsonism and occupational exposure to pesticides

  2001cites this paper
• Enfermedades neurodegenerativas que cursan con demencia

  2000cites this paper
• Neuronal nicotinic receptors in synaptic functions in humans and rats: physiological and clinical relevance.

  2000cites this paper
• Involvement of Neuronal Nicotinic Receptors in Disease

  2000cites this paper
• Nicotinic Receptor Activation in Human Cerebral Cortical Interneurons: a Mechanism for Inhibition and Disinhibition of Neuronal Networks

  2000cites this paper
• Parkinson's disease mortality and pesticide exposure in California 1984-1994.

  2000cites this paper
• Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.

  2000cites this paper
• Parkinsonism: differential age‐trend in Helicobacter pylori antibody

  2000cites this paper
• Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide.

  2000cites this paper
• Pesticides and Parkinson's disease.

  1999cites this paper
• Aspects of Parkinson's disease. Epidemiology, risk factors and ECT in advanced disease

  1999cites this paper
• Disorders of the Basal Ganglia and Their Modern Management

  1999cites this paper
• A Case-Referent Study of Extrapyramidal Signs (Preparkinsonism) in Rural Communities of Israel

  1998cites this paper
• The Epidemiology of Parkinson’s Disease in an Australian Population

  1998cites this paper
• Genetic and environmental risk factors in Parkinson's disease.

  1998cites this paper
• Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991.

  1996cites this paper
• EPIDEMIOLOGY OF PARKINSON'S DISEASE

  1996cites this paper
• Rate and Cost of Hospitalizations for Asthma in Quebec : An Analysis of 1988 / 89 , 1989 / 90 and 1994 / 95 Data

  year unknowncites this paper